Bookmark
Forward
Explore Literature Results
QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=0F62AD57107DF9D49BFCDEB9401817EC;jsessionid=2F2A3216137F3E590CE727FF0B4C92D2;jsessionid=83FB169AC20A50822260F9974618FB02;jsessionid=00A77FF45DE8089BE4B95E95CDD70E56;jsessionid=8F02459A0647DEC8EB5B304DFEAAA0DC (gene)
Most Relevant Literature
- Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
- ATXN2 is a target of N-terminal proteolysis.
- ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
- TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.
- Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…
Most Relevant Clinical Trials
There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=0F62AD57107DF9D49BFCDEB9401817EC;jsessionid=2F2A3216137F3E590CE727FF0B4C92D2;jsessionid=83FB169AC20A50822260F9974618FB02;jsessionid=00A77FF45DE8089BE4B95E95CDD70E56;jsessionid=8F02459A0647DEC8EB5B304DFEAAA0DC
Explore Clinical Trials Results
